tiprankstipranks
Trending News
More News >
Amplifon S.p.A. (IT:AMP)
:AMP
Advertisement

Amplifon S.p.A. (AMP) AI Stock Analysis

Compare
38 Followers

Top Page

IT:AMP

Amplifon S.p.A.

(AMP)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 4o)
Rating:55Neutral
Price Target:
€13.50
▲(1.28% Upside)
Amplifon S.p.A.'s stock score is primarily influenced by its stable financial performance, despite challenges with revenue growth and leverage. The technical analysis indicates a bearish trend, with the stock being oversold. Valuation metrics suggest the stock is relatively expensive, but the dividend yield offers some compensation. The absence of recent earnings call insights or notable corporate events limits additional context.
Positive Factors
Business Model Strength
Amplifon's diversified revenue streams, including direct sales, online sales, and after-sales services, provide a robust business model that supports long-term stability and customer retention.
Cash Generation Ability
Positive free cash flow growth indicates Amplifon's ability to generate cash efficiently, supporting reinvestment in business operations and potential debt reduction.
Market Position
As a global leader in hearing aids, Amplifon benefits from strong brand recognition and market reach, which can drive sustained revenue and competitive advantage.
Negative Factors
Declining Revenue Growth
Negative revenue growth suggests challenges in maintaining sales momentum, which could impact long-term profitability and market share if not addressed.
Increased Leverage
Higher leverage increases financial risk and may constrain Amplifon's ability to invest in growth opportunities, affecting its financial flexibility.
Decreased Profitability
A declining net profit margin indicates reduced profitability, which could hinder Amplifon's ability to reinvest in its business and reward shareholders.

Amplifon S.p.A. (AMP) vs. iShares MSCI Italy ETF (EWI)

Amplifon S.p.A. Business Overview & Revenue Model

Company DescriptionAmplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound. The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices. It also provides fitting of customized products. As of March 18, 2022, the company operated a network of approximately 9,200 points of sale in 25 countries and 5 continents. The company also sells its products through 1,350 franchisees. It has operations in Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company was founded in 1950 and is headquartered in Milan, Italy.
How the Company Makes MoneyAmplifon generates revenue primarily through the sale of hearing aids and audiological services. The company operates a direct-to-consumer model through its extensive network of retail stores and online platforms, where customers can purchase hearing aids and receive professional fitting services. Key revenue streams include sales from hearing aids, ongoing maintenance and aftercare services, and audiological assessments. Additionally, Amplifon has established partnerships with various healthcare providers and insurance companies, which facilitate the distribution of its products and broaden its customer base. The company also benefits from strategic alliances with leading hearing aid manufacturers, allowing it to offer a diverse range of products and maintain competitive pricing.

Amplifon S.p.A. Financial Statement Overview

Summary
Amplifon S.p.A. demonstrates stable profitability and cash flow management, but faces challenges with declining revenue growth and increased leverage. The company needs to address these issues to maintain financial health and shareholder value.
Income Statement
65
Positive
Amplifon S.p.A. shows a stable gross profit margin around 56%, indicating efficient cost management. However, the net profit margin has decreased to 5.2% in the TTM, reflecting reduced profitability. The revenue growth rate is negative in the TTM, suggesting a decline in sales performance. EBIT and EBITDA margins have also slightly decreased, indicating potential operational challenges.
Balance Sheet
60
Neutral
The company's debt-to-equity ratio has increased to 1.81 in the TTM, indicating higher leverage and potential financial risk. Return on equity has decreased to 11.4%, suggesting reduced profitability for shareholders. The equity ratio remains stable, reflecting a balanced asset structure.
Cash Flow
70
Positive
Free cash flow growth is positive at 2.6% in the TTM, showing improved cash generation. The operating cash flow to net income ratio is below 1, indicating potential cash flow constraints. However, the free cash flow to net income ratio is strong at 0.72, suggesting efficient cash utilization.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.42B2.41B2.26B2.12B1.95B1.56B
Gross Profit1.36B1.36B548.45M1.18B1.11B863.16M
EBITDA549.97M557.25M522.01M513.82M468.72M361.67M
Net Income126.08M145.37M155.14M178.53M157.78M101.00M
Balance Sheet
Total Assets3.86B3.99B3.69B3.58B3.52B3.23B
Cash, Cash Equivalents and Short-Term Investments242.69M288.85M194.00M229.54M318.44M554.02M
Total Debt1.83B1.72B1.52B1.50B1.61B1.56B
Total Liabilities2.85B2.84B2.59B2.54B2.59B2.43B
Stockholders Equity1.01B1.15B1.10B1.04B925.18M800.88M
Cash Flow
Free Cash Flow318.25M366.19M271.89M342.99M348.97M330.63M
Operating Cash Flow442.77M449.35M413.54M458.62M462.37M391.47M
Investing Cash Flow-257.99M-335.10M-261.48M-193.78M-533.61M-134.28M
Financing Cash Flow-92.17M-18.85M-135.06M-353.80M-208.64M151.52M

Amplifon S.p.A. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price13.33
Price Trends
50DMA
14.38
Negative
100DMA
15.39
Negative
200DMA
17.62
Negative
Market Momentum
MACD
-0.41
Positive
RSI
37.79
Neutral
STOCH
47.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:AMP, the sentiment is Negative. The current price of 13.33 is below the 20-day moving average (MA) of 13.74, below the 50-day MA of 14.38, and below the 200-day MA of 17.62, indicating a bearish trend. The MACD of -0.41 indicates Positive momentum. The RSI at 37.79 is Neutral, neither overbought nor oversold. The STOCH value of 47.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IT:AMP.

Amplifon S.p.A. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
€561.50M31.911.72%12.82%7.36%
63
Neutral
€486.78M22.335.08%11.25%-76.44%
55
Neutral
€3.28B28.3811.68%2.17%2.05%-25.46%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IT:AMP
Amplifon S.p.A.
13.33
-10.25
-43.46%
IT:PHN
PharmaNutra SpA
56.90
1.92
3.49%
IT:HI
Health Italia SpA
289.00
158.00
120.61%
IT:GHC
Garofalo Health Care S.P.A.
5.46
-0.15
-2.60%
IT:GPI
GPI SpA
16.64
6.44
63.14%
IT:SVS
Svas Biosana S.p.A.
8.30
1.70
25.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 19, 2025